Preface |
|
xi | |
|
|
Opening Remark |
|
|
The Role of Technology in Hemodialysis |
|
|
1 | (12) |
|
|
Vascular Access |
|
|
Vascular Access Use and Outcomes: Results from the DOPPS |
|
|
13 | (7) |
|
|
How to Achieve a High Rate (90%) of Native Arteriovenous Fistulae |
|
|
20 | (11) |
|
|
Diagnostic Methods for Vascular Access: Access Flow Measurements |
|
|
31 | (7) |
|
|
Temporary Vascular Access for Hemodialysis Treatment. Current Guidelines and Future Directions |
|
|
38 | (8) |
|
|
|
Prosthetic Devices for Vascular Access |
|
|
46 | (8) |
|
|
|
|
Effect of Hemodynamic Conditions on Arteriovenous Fistula for Hemodialysis Access |
|
|
54 | (6) |
|
|
|
|
|
Quality Assurance and Continuous Quality Improvement in the Management of Vascular Access |
|
|
60 | (10) |
|
|
Dialysis Membranes |
|
|
Membranes for Dialysis. Composition, Structure and Function |
|
|
70 | (8) |
|
|
|
|
Methods of Sterilisation and Their Effects on Membrane Performance and Safety |
|
|
78 | (7) |
|
|
|
|
Nano-Controlled Membrane Spinning Technology: Regulation of Pore Size, Distribution and Morphology of a New Polysulfone Dialysis Membrane |
|
|
85 | (10) |
|
|
Vitamin E-Modified Dialyzers |
|
|
95 | (11) |
|
|
Modified Cellulose Triacetate Membranes |
|
|
106 | (5) |
|
|
The AN69ST Dialysis Membrane. A New Approach for Reducing Systemic Heparinization |
|
|
111 | (9) |
|
|
Hemodialyzers |
|
|
Flow Distribution and Cross Filtration in Hollow Fiber Hemodialyzers |
|
|
120 | (9) |
|
|
|
|
|
|
Optimal Use of Hemodialyzers |
|
|
129 | (9) |
|
|
|
Sterilization Procedures and Biocompatibility |
|
|
138 | (8) |
|
|
|
|
|
Computerized Selection of Membranes and Hemodialyzers |
|
|
146 | (12) |
|
|
|
|
Adsorbents |
|
|
Adsorbents: From Basic Structure to Clinical Application |
|
|
158 | (7) |
|
|
|
|
Biocompatibility of Sorbent Systems |
|
|
165 | (5) |
|
|
Sorbent Augmented Dialysis Systems |
|
|
170 | (11) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Use of Adsorbents in ARF Therapy |
|
|
181 | (8) |
|
|
|
|
|
|
|
|
Dialytic Techniques |
|
|
Low Flux Dialysis? Still a Role |
|
|
189 | (4) |
|
|
High-Flux Hemodialysis and Hemodiafiltration. Impact on Outcome |
|
|
193 | (8) |
|
|
|
|
|
On-Line Hemodiafiltration. Gold Standard or Top Therapy? |
|
|
201 | (11) |
|
|
|
New Options for On-Line Hemodiafiltration |
|
|
212 | (9) |
|
|
|
|
|
|
|
On-Line Hemofiltration. Old Concept -- New Approach |
|
|
221 | (6) |
|
|
The Ideal Hemodialysis Machine |
|
|
227 | (6) |
|
Dialysis Machines, Monitoring and Biofeedback |
|
|
Blood Volume Monitoring Systems and Biofeedback |
|
|
233 | (12) |
|
|
|
Blood Temperature Monitor: A Novel Tool in the Management of Dialysis-Induced Hypotension |
|
|
245 | (9) |
|
|
|
|
Optimization of Convection on Hemodiafiltration by Transmembrane Pressure Monitoring and Biofeedback |
|
|
254 | (6) |
|
|
|
|
|
|
Potassium Profiling in Acetate-Free Biofiltration |
|
|
260 | (8) |
|
|
|
|
|
On-Line Clearance: Advanced Methodology to Monitor Adequacy of Dialysis at No Cost |
|
|
268 | (4) |
|
|
|
272 | (7) |
|
|
|
|
Data Acquisition and Management |
|
|
Information Technology Applied to Hemodialysis |
|
|
279 | (8) |
|
|
|
|
Practical Approach to Data Collection in a European Dialysis Network |
|
|
287 | (6) |
|
|
|
|
Data Management and Quality Assurance for Dialysis Network |
|
|
293 | (7) |
|
|
|
|
|
|
|
|
|
Continuous Quality Improvement for a Hemodialysis Network |
|
|
300 | (11) |
|
|
|
Pre-End-Stage Renal Disease and Dialysis Programs: The View of the Manager |
|
|
311 | (6) |
|
Dialysis Quality and Composition |
|
|
Water Treatment for Hemodialysis |
|
|
317 | (8) |
|
|
|
|
|
|
325 | (7) |
|
|
|
|
|
|
On-Line Fluid Preparation |
|
|
332 | (6) |
|
|
Sodium Content and Profiling |
|
|
338 | (6) |
|
|
|
|
|
|
Dialysate/Infusate Composition and Infusion Mode in On-Line Hemodiafiltration |
|
|
344 | (6) |
|
|
|
|
|
Dialysate/Infusate Calcium and Magnesium |
|
|
350 | (7) |
|
|
|
|
Dialysate/Infusate Buffer Modulation in Dialysis |
|
|
357 | (7) |
|
Chronic Inflammation |
|
|
Chronic Inflammation: An Overview |
|
|
364 | (7) |
|
|
|
Oxidant Stress in Hemodialysis Patients |
|
|
371 | (8) |
|
|
|
|
End-Stage Renal Disease: A Slowly Progressive Systemic Inflammatory Response Syndrome |
|
|
379 | (7) |
|
|
|
LDL Modification during Hemodialysis. Markers for Oxidative Stress |
|
|
386 | (10) |
|
|
Anemia Management |
|
|
Erythropoietin Therapy in Europe: Results from the DOPPS |
|
|
396 | (7) |
|
|
Clinical Experience with Darbepoetin-Alfa (Aranesp®) |
|
|
403 | (5) |
|
|
|
|
Once-Weekly Epoetin-Beta in Renal Anemia: The Clinical Evidence |
|
|
408 | (4) |
|
|
Iron Therapy in Hemodialysis Patients: How and When? |
|
|
412 | (14) |
|
|
|
|
Carnitine as Adjuvant Therapy in the Management of Renal Anemia |
|
|
426 | (5) |
|
|
|
|
|
|
Erythropoietin Therapy and the Cardiovascular System |
|
|
431 | (5) |
|
Author Index |
|
436 | (2) |
Subject Index |
|
438 | |